Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
SEQUEL IIE AND ASSOCIATED SUPPLIES & REAGENTS FOR STONEVILLE, MS AND HILO, HI is a federal award for Usda Ars Sea Aao Acq/Per Prop held by Pacific Biosciences of California, Inc. Estimated value $806K ($806K obligated). Current period of performance ends Sep 23, 2022. Place of performance: MENLO PARK CA. Related solicitation RQ-ARS-21-0058.
SEQUEL IIE AND ASSOCIATED SUPPLIES & REAGENTS FOR STONEVILLE, MS AND HILO, HI
Recompete timing
PublicCurrent PoP ended Sep 23, 2022 (1448 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordPacific Biosciences of California, Inc — $7.8M obligated across 81 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 12405B21F0427?
12405B21F0427 (SEQUEL IIE and associated supplies reagents) is a Usda Ars Sea Aao Acq/Per Prop award with a potential value of $806K, currently held by Pacific Biosciences of California, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 12405B-21-F-0427?
12405B-21-F-0427 is the dashed form of PIID 12405B21F0427 (SEQUEL IIE and associated supplies reagents), held by Pacific Biosciences of California, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 12405B21F0427?
Usda Ars Sea Aao Acq/Per Prop awarded 12405B21F0427 to Pacific Biosciences of California, Inc (potential $806K).
Who is the incumbent on 12405B21F0427?
Pacific Biosciences of California, Inc is the incumbent with $7.8M across 81 related awards in SCOUT’s public footprint. The current period of performance ends Sep 23, 2022.
When does Pacific Biosciences of California, Inc’s 12405B21F0427 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 23, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 12405B21F0427 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.